We provide an update into the current knowledge of the PD‐1/PD-L1 axis and discuss the growing interest of this axis in the diagnosis, prognosis, and management of thyroid diseases within the context of autoimmunity and cancer, while embracing personalized medicine. This evidence concerns the gene CD274 and cancer.